Imunon Inc (NASDAQ: IMNN) on Tuesday, soared 3.07% from the previous trading day, before settling in for the closing price of $0.79. Within the past 52 weeks, IMNN’s price has moved between $0.48 and $3.65.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -20.00%. The company achieved an average annual earnings per share of 22.22%. With a float of $13.79 million, this company’s outstanding shares have now reached $14.50 million.
Considering the fact that the conglomerate employs 33 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 92.85%, operating margin of -297.19%, and the pretax margin is -68948.26%.
Imunon Inc (IMNN) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Imunon Inc is 4.89%, while institutional ownership is 14.28%. The most recent insider transaction that took place on Aug 15 ’24, was worth 24,500. In this transaction President and CEO of this company bought 25,000 shares at a rate of $0.98, taking the stock ownership to the 264,166 shares. Before that another transaction happened on Aug 15 ’24, when Company’s Executive Chairman of Board bought 25,000 for $1.03, making the entire transaction worth $25,750. This insider now owns 353,346 shares in total.
Imunon Inc (IMNN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 22.22% per share during the next fiscal year.
Imunon Inc (NASDAQ: IMNN) Trading Performance Indicators
Imunon Inc (IMNN) is currently performing well based on its current performance indicators. A quick ratio of 2.30 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.89, a number that is poised to hit -0.36 in the next quarter and is forecasted to reach -1.13 in one year’s time.
Technical Analysis of Imunon Inc (IMNN)
Compared to the last year’s volume of 0.9 million, its volume of 1.03 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 29.04%. Additionally, its Average True Range was 0.06.
During the past 100 days, Imunon Inc’s (IMNN) raw stochastic average was set at 23.33%, which indicates a significant decrease from 33.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.91% in the past 14 days, which was lower than the 68.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.8624, while its 200-day Moving Average is $1.1435. Nevertheless, the first resistance level for the watch stands at $0.8253 in the near term. At $0.8357, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.8538. If the price goes on to break the first support level at $0.7968, it is likely to go to the next support level at $0.7787. Now, if the price goes above the second support level, the third support stands at $0.7683.
Imunon Inc (NASDAQ: IMNN) Key Stats
Market capitalization of the company is 11.82 million based on 14,501K outstanding shares. Right now, sales total 0 K and income totals -19,510 K. The company made 0 K in profit during its latest quarter, and -4,850 K in sales during its previous quarter.
